Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Retail Clinics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Retail Clinics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. U.S. Retail Clinics Market: Ownership Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Retail Clinics Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
4.3. Retail Owned
4.3.1. Retail Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4. Hospital Owned
4.4.1. Hospital Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 5. U.S. Retail Clinics Market: Diagnosis Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Retail Clinics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
5.3. Immunization
5.3.1. Immunization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. General Symptoms
5.4.1. General Symptoms Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Injuries
5.5.1. Injuries Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. General Screening & Examination
5.6.1. General Screening & Examination Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7. Acute Respiratory Disease & Infection
5.7.1. Acute Respiratory Disease & Infection Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.8. Urinary Tract Infections
5.8.1. Urinary Tract Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.9. Ear Infections
5.9.1. Ear Infections Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.10. Sprains, Strains, and Fractures
5.10.1. Sprains, Strains, and Fractures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.11. Others
5.11.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 6. U.S. Retail Clinics Market: Regional Estimates & Trend Analysis
6.1. U.S. Retail Clinics Market Share, By Region, 2023 & 2030, USD Million
6.2. Southeast
6.2.1. Southeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3. Midwest
6.3.1. Midwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Southwest
6.4.1. Southwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Northeast
6.5.1. Northeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6. West
6.6.1. West U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CVS Health
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Kroger Health
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Walgreens
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Advocate Health Care
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Kaiser Foundation Health Plan, Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Walmart
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Bellin Health Systems
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Geisinger Health
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Target
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives